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Structured abstract 
Ethnopharmacological relevance 
Regression analyses of local medicinal floras are considered potentially useful when 
prioritising candidate plant taxa for pharmacological / bioprospecting investigations. 
Aim of study 
To identify plant orders and subsequently families most highly selected for by traditional 
healers in southern Africa. 
Materials and methods 
Using data sourced from the SANBI MedList database, the most comprehensive 
inventory of ethnomedicinal plants for the Flora of southern Africa region, taxa were 
grouped by order. A least squares regression analysis was used to test the null hypothesis 
 2
that the use of these plants by traditional healers is strictly random. Of ‘hot’ orders 
subsequently identified, characteristics of taxa therein were assessed to better determine 
the roles played by i) growth forms, and ii) inherent chemical diversity, in plant 
selections by ethnomedicinal practitioners.  
Results 
Analyses identified seven principally ‘hot’ plant orders (Malpigiales, Fabales, 
Gentianales, Asteraceae, Solanales, Malvales and Sapindales) and ‘hot’ families therein 
from a total of 55 regional ethnomedicinal orders. Five ‘cold’ ethnomedicinal orders 
(Rosales, Proteales, Poales, Asparagales and Caryophyllales) were shown to be 
significantly less represented in the medicinal flora than predicted. No clear growth form 
preferences were identified across orders. The presence of highly diverse bioactives was 
evident in the ‘hottest’ plant families from ‘hot’ plant orders. 
Conclusions 
These 12 outliers identified by the regression analyses allowed for the falsification of the 
null hypothesis. Indications are that ‘hot’ taxa are selected traditionally on the basis of 
bioactivity, which is reflected in chemical diversity.  
 
Abstract 
 
Using data sourced from the SANBI MedList database, the most comprehensive 
inventory of ethnomedicinal plants for the Flora of southern Africa region, taxa were 
grouped by order. A least squares regression analysis was used to test the null hypothesis 
that the use of these plants by traditional healers is strictly random. The above approach, 
following a North American study by Moerman (1979), sought to identify plant orders 
and subsequently families most highly selected for by traditional healers in southern 
Africa. The analyses identified seven principally ‘hot’ plant orders (Malpigiales, Fabales, 
Gentianales, Asteraceae, Solanales, Malvales and Sapindales) and ‘hot’ families therein 
from a total of 55 regional ethnomedicinal orders. Five ‘cold’ ethnomedicinal orders 
(Rosales, Proteales, Poales, Asparagales and Caryophyllales) were shown to be 
significantly less represented in the medicinal flora than predicted. These 12 outliers 
allowed for the falsification of the null hypothesis. Such regression analyses of local 
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medicinal floras are considered potentially useful when prioritising candidate plant taxa 
for pharmacological / bioprospecting investigations. Growth forms of taxa in ‘hot’ orders 
were assessed to better determine the role this factor plays in plant selection by 
ethnomedicinal practitioners. Results indicated no clear growth form preferences across 
orders, but rather selection in line with growth forms naturally dominating those orders. 
However, when the dominant chemical compound classes of the ‘hottest’ plant families 
from ‘hot’ plant orders were considered, the presence of highly diverse bioactives was 
revealed. Thus ‘hot’ taxa are probably selected traditionally on the basis of bioactivity 
which is reflected in chemical diversity.  
 
1. Introduction 
 
The historical development of pharmaceuticals and other novel drugs has proceeded 
primarily through the extraction of efficacious compounds from plants (Farnsworth and 
Bingel, 1977), identified through a variety of bioactivity screening programs (Hunter, 
2001). Selection of plants for extract screening can be achieved in one of two ways (Cox, 
1990): i) random selection, where no regard is taken of the taxonomic affinities, 
ethnobotanical context or other intrinsic qualities; or ii) targeted or focused selection, by 
means of phylogenetic surveys (close relatives of plants known to contain useful 
compounds are sampled), ecological surveys (plants in particular habitats with particular 
growth habits), or ethnopharmacological surveys (identifying plants used by indigenous 
peoples to target specific diseases)(Farnsworth and Bingel, 1977). The low probability of 
finding useful compounds in random plant screening programmes (approx. one plant 
sample in 10 000 will show promising activity of interest to researchers), particularly in 
areas of high biodiversity, is one reason why private drug companies are reluctant to 
engage in bioprospecting de novo (Macilwain, 1998; Soejarto, 1993). Taxol is a notable 
exception discovered through random screening (Cox and Balick, 1994; Cragg et al., 
1993). 
Focused selection and ethnobotanical screens in particular, have shown relatively 
high success rates (Cox, 1990, 1994; Farnsworth, 1990; Farnsworth et al., 1985). Ethno-
directed research has reportedly contributed approximately 74% of all pharmaceutical 
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drugs derived from plants (Farnsworth et al., 1985). Prospecting of plants and most 
particularly medicinal floras is likely to continue into the foreseeable future, due to 
complementary advances in bioassay techniques (Tyler, 1986), and historical successes. 
However, given the high research and development costs associated with novel drug 
development, optimisation of the discovery phase of the bioprospecting process is 
continually sought after, especially in situations where the resource base is extensive as 
well as highly diverse. One such bioresource-rich environment is the Flora of southern 
Africa (FSA) region which includes more than 70 major vegetation units (Acocks, 1953) 
nested within the subcontinent’s seven floristically distinct biomes (Rutherford, 1997). 
The FSA region includes the following countries: Namibia, Botswana, Swaziland, 
Lesotho and South Africa (Germishuizen and Meyer, 2003), occupying the area south of 
the Kunene, Okavango and Limpopo Rivers. An estimated 80% of the 24,300 plant taxa 
recorded for the FSA region are endemic (Goldblatt, 1978). The flora is estimated to 
constitute approximately 10% of global plant diversity, of which only a relatively small 
percentage has been investigated pharmacologically (Eloff, 1998).  
The various focused methods that have been employed to identify efficacious 
ethnomedicinal plants worthy of research vary (Trotter, 1986) include: i) cross-cultural 
comparisons, where plant efficacies are inferred from the extent to which they are used 
across different ethnic groups or cultures; ii) the extent of selective borrowing and 
diffusion of herbal remedies by various ethnic groups or cultures; iii) market and 
household garden-based studies which identify popular plants or those with high trade 
volumes; iv) the collection and analysis of case histories and related plant use anecdotes 
which may prove to be instructive. In addition, Buenz et al. (2005) reported that 
correlations between ancient and current plant use practices suggest that the taxa in 
question are indeed effective treatments. The question of how ethnomedicinal 
practitioners select plants has also often been posed (Moerman, 1979, 1991). Adler and 
Hammett (1973) postulated that such plant selection is undertaken on a strictly symbolic 
basis, and that reported therapeutic benefits are of a placebo effect. If so, it could be 
assumed that symbolic selection of plant taxa is random, in so far as the proportion of 
taxa selected from any given family or order will be equal. Moerman (1991) proposed 
this null-hypothesis in an analysis of the patterns of collective ethnobotanical plant use by 
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Native Americans. However, by means of a least squares regression analysis, he 
identified a distinct bias towards the use of certain taxonomic groups (‘hot’ taxa) in the 
treatment of particular diseases, and so disproved the null hypothesis. Moerman 
demonstrated that the use of regression analyses is a simple yet effective means of 
reducing a large number of disparate ethnomedicinal taxa to a manageable group which 
are likely to display relevant bioactivities. Analyses comparing the actual number of 
medicinal taxa in a family with the probability distribution for numbers of medicinal taxa 
in that family (using a random test hypothesis) showed results comparable with the least 
squares regression analysis (Moerman and Estabrook, 2003). On the assumption that such 
‘hot’ taxa are efficacious, their preferential selection for screening in pharmacological 
and bioprospecting programmes would be justified. 
Clark et al. (1997) identified relevant criteria and formulated a semi-quantitative 
scoring system to help streamline plant selection for plant molluscicidal agents. Examples 
of desirable characteristics (criteria) included relative toxicity, availability of plants, plant 
growth characteristics, localisation of activity (plant part), physical and chemical 
stability, ethnobotanical use, ease of extraction and ease of application. The system of 
Clark and co-workers allowed for the identification of 63 short-listed taxa, of which six 
were prioritised for preliminary screening. Their system sought to identify species that 
could be utilised in a relatively crude way by communities and as such has limited 
application for more sophisticated bioprospecting approaches. However, the objectivity 
of such plant candidate selections and the ease with which the weighting system could be 
modified were highlighted by the authors as key advantages. A plant selection procedure 
applied to select antimalarial drug candidates (Clarkson et al., 2004) was subsequently 
modelled on that of Clark and her co-workers, and proved highly successful: extracts of 
49% of species assayed exhibited promising antiplasmodial activity (IC50 ≤ 10µg/ml). 
Whilst criteria related to ethno-directed selection were duly included in the system of 
Clarkson et al. (2004), viz. the traditional use of the species against the target disease, and 
popularity in the local ethnomedicinal plant trade, a further generic element could have 
been included to further maximise the likelihood of identifying positive screening leads. 
This criterion relates to the identification (and subsequent) weighting of ‘hot’ taxonomic 
groups identified through elucidation of biases towards their use by traditional medical 
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practitioners. As a proxy, Clarkson et al. (2004) had weighted the chemotherapeutic 
(antiplasmodial) potentials of the plant families in view, based on documented 
pharmacological activities of their constituent compound classes. 
The present study has sought to identify plant orders and families within the 
highly diverse ethnomedicinal flora of southern Africa, towards which biases by user 
groups are demonstrable. The identification of such generic ‘hot’ taxonomic groups is 
expected to facilitate the prioritising of plant selections for broad-based bioprospecting, 
and pharmacological screening. Further, assessments of growth forms of regional 
representatives of ‘hot’ orders, and their phytochemical diversity are undertaken to 
explore reasons for their selection by practitioners. 
 
2. Materials and methods 
The overall approach to data organisation and analysis is presented in Figure 1. 
 
Insert Figure 1 
 
2.1 Data source and organisation 
 
The SANBI MedList database (SANBI, 2004) held data on 3371 taxa (both 
indigenous and naturalised), from 1227 genera grouped into 211 families. This dataset 
was an electronic update of the annotated ethnomedicinals checklist of Arnold et al. 
(2002). In the current study, taxonomic groupings at genus and species levels conformed 
to the PRECIS database (SANBI, 2005), a curated list of all valid plant taxon names for 
the FSA region, while groupings at order and family levels followed APG II (2003) for 
angiosperms, with the exception of the Balanophoraceae, Bruniaceae and Vahliaceae. To 
accommodate currently these three families, which were not grouped into any order by 
APG II (2003), the Balanophoraceae were grouped with the Santalales, and the 
Bruniaceae and Vahliaceae with the Rosales, consistent with Cronquist (1988). 
Gymnosperms and pteridophytes were classified according to Bowe et al. (2000) and 
Chaw et al. (2000), and Germishuizen and Meyer (2003) respectively. The subsequent 
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regrouping enumerated a total of 193 families in 55 orders. Plants in the database 
exhibited a wide spectrum of growth forms, including trees, shrubs, climbers, herbs and 
geophytes. 
 
2.3 Primary regression analyses 
 
A least squares regression analysis measuring the association between the ethnomedicinal 
taxa and the total number of taxa present in the FSA region (both indigenous and 
naturalised plants included)(SANBI 2005) was performed. The entire dataset was 
incorporated into the primary analysis. A mathematical model for predicting the 
association between plant orders with ethnomedicinal taxa and the total number of taxa in 
those orders was obtained from the least-squares regression analysis. Two assumptions 
were made: firstly, that due to the extensive literature review conducted during the 
compilation of the SANBI MedList database (Arnold et al., 2002), the data constituted a 
census rather than a sample of the ethnomedicinal taxa in southern Africa. This 
assumption eliminated the need for statistical tests of significance designed to give 
confidence that the sample was representative of a larger data body. Census data implies 
that all individuals in the population were accounted for. The second assumption was that 
ethnomedicinal taxa used in the analysis are the only southern African plants with any 
ethnomedicinal potential. Data therefore included i) all recorded ethnomedicinal taxa in 
the FSA (grouped by order), and ii) the total number of taxa in the FSA (grouped by 
order). The population correlation coefficient (ρ) indicates the strength of the relationship 
between these two groups of variables. Total number of orders and families were 
considered independent variables, and ethnomedicinal taxa as dependant variables. 
Residual values were calculated by subtracting the predicted number of ethnomedicinal 
taxa used per order from the actual number of ethnomedicinal taxa used per order. The 
population variance calculated from these residuals was used to identify all outliers, i.e. 
orders which showed notably different values from those predicted. Ethnomedicinal taxa 
(grouped by order) were plotted against total taxa (grouped by order), and the regression 
line (equation obtained from the regression analysis) was overlaid to allow for visual 
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assessment of i) any obvious patterns/relationships and ii) the position of any outliers. 
Residual values correspond to the vertical distance from each datum point to the 
regression line (y-ŷ). Positive outliers (orders selected significantly more often than 
predicted) were further analysed at family level. This required a regression analysis for 
all ethnomedicinal taxa (grouped by family) against total taxa (grouped by family). Data 
for families within the selected orders were then filtered out for further scrutiny.  
 
2.3 Secondary regression analyses 
 
Outlying orders and families identified in the primary regression analyses were removed 
from the data set, and the regression analyses performed again to allow further 
partitioning of the data. The population variance of residual values was determined and 
used as a cut-off to identify outlying orders and families. Total taxa (grouped by orders or 
families) were considered independent variables and ethnomedicinal taxa (grouped by 
orders or families) as dependant variables. 
 
2.4 Analysis of plant growth forms 
 
In addition to the above analyses, an investigation of plant growth forms of plants present 
in the highly selected orders was undertaken. Plant growth form data were extracted from 
Germishuizen and Meyer (2003) and grouped according to four nominal categories, 
namely: geophyte, climber, tree/shrub and herb/dwarf shrub. All taxa in the respective 
orders were included, regardless of their variable status as annuals or perennials. For this 
analysis, the chemical defence strategies of annual and perennial taxa were assumed to 
not differ. 
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2.5 Evaluation of phytochemical trends in principal ‘hot’ families 
 
A data mining exercise which summarised the important compound classes known to 
occur in selected ‘hot’ families was undertaken. ‘Hot’ families were those with the 
highest residual value in each of the highly selected orders. Compounds known to have 
been isolated from taxa in ‘hot’ families were compiled from the Dictionary of Natural 
Products (DNP)(DNP, 2005), and then grouped according to class, as defined in the 
DNP. Proportions of compound classes present in each selected family were determined 
to assess prevalence. The phytochemical data are limited and undoubtedly do not 
represent all compounds/compound classes present. However, the DNP was the most 
comprehensive data source available and data are assumed to be sufficiently 
representative to allow an overview of the important classes. Compound classes notably 
absent or infrequently listed for the relevant families were also identified. Notably, 
molecular trees based on rbcL DNA analyses provide a useful framework for assessing 
the comparative merits of secondary compound classes as chemotaxonomic characters 
(Grayer et al., 1999). For this reason plant families and orders (excluding the 
Pteridophyta) in the current study were grouped according to recently published 
phylogenetic trees, as described above (2.1). 
 
3. Results and discussion 
 
The results of the primary least squares regression analysis (Table 1) indicated the 
presence of a particularly strong linear relationship between ethnomedicinal plant taxa 
(grouped by order), and the total number of taxa in those orders, i.e. the value of ρ is very 
close to +1. Figure 2 provides further evidence of this positive relationship. Similar 
results were later obtained for ethnomedicinal taxa grouped by family (Table 3).  
 
Insert Table 1 
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Residual values obtained from the regression analysis of ethnomedicinal taxa grouped by 
plant order ranged from –118.9 to +103.5 (residual values for each of the 55 orders are 
not presented, rather only those 12 orders significantly greater or less than predicted). 
The model was able to account for 86% (ρ2 = 0.86) of the variation in the y-values (Table 
1). As such, it was necessary to distinguish which orders could be considered outliers, i.e. 
farthest from the regression line. The population variance of all 55 order residuals (37.47) 
was employed as a cut-off, leaving 12 orders as outliers (seven positive and five 
negative)(Table 2). Plants in these orders were considered to have been selected either far 
more or far less than plants from other orders in the region. The magnitude of the 
outlying residuals falsified the null hypothesis that traditional user-groups in the region 
select plants for medicinal purposes in a wholly random manner. The high percentage of 
variation that the statistical model was able to account for, and the strong positive 
correlations observed in the regression plots, signified that the model performed well as a 
predictive tool. A direct comparison of the current results with those presented by 
Moerman (1991) has not been undertaken, due to the very different floras present in the 
two regions (North America and southern Africa). 
 
Insert Table 2 
 
The 55 orders containing ethnomedicinal taxa were plotted against the total 
number of taxa present within those orders in the FSA region (Figure 2). The strength of 
the positive relationship (ρ) is particularly evident. The prominent seven positive, and 
five negative, outlying orders which influence both the coefficient of determination (ρ2) 
and the reliability of predictions made from the line of best fit, are indicated. 
  
Insert Figure 2 
Given the extensive botanical diversity of the FSA region, taxa identified through 
the analysis of plant orders are numerous – far more than could reasonably be included in 
most screening programmes. For this reason, residual values of families within these 
orders were also calculated (Table 3). Although analyses at family level provides for 
additional focus, taxa numbers at this level may still be too great e.g. the number of FSA 
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taxa in the Asteraceae alone is 2681 (SANBI, 2005). In such instances, it may be 
necessary to perform analyses at the generic level to obtain more definition for focused 
screening. To better understand how families constituting the outlying orders (Table 2) 
contributed towards their popularity in ethnomedicinal use, a regression analysis for all 
families was performed; only data for families which constitute the positive outlying 
orders are presented (Table 3). Families with high positive residual values contributed 
most to the outlier status assigned to their respective orders.  
Outlying ‘cold’ orders which occur below the regression line (Figure 2), and 
therefore selected less often by ethnomedicinal practitioners, are of particular interest. 
Five were identified from a total of 55 orders in the FSA region. It is reasonable to argue 
that these, the Rosales, Proteales, Poales, Asparagales and Caryophyllales should be 
weighted negatively in candidate selection systems. Plants in these orders may have 
characteristics which result in their more modest usage. The Poaceae, for example, which 
are highly utilised by browsers rely primarily on physical attributes (e.g., sharp awns, 
high lectin and/or high silica content), growth form and compensatory growth rather than 
secondary metabolite production for defence (Lindroth, 1988; Peumans and Van Damme, 
1995). The Poaceae also contain numerous food plants (e.g. maize, millet, etc.) and as a 
group may generally produce insufficient quantities of bioactive compounds to be of 
medicinal interest to humans. If this is the case, the same result is likely to be evident 
globally; it is therefore not surprising that taxa most rarely used medicinally by Native 
Americans include the Caryophyllaceae and Poaceae (Moerman, 1991). Both these 
families are in orders selected significantly less often than others by ethnomedicinal 
practitioners in southern Africa (Table 2; Figure 2). 
 
Insert table 3 
 
When outlying orders and families previously identified as outliers were removed 
from the dataset and secondary regression analyses performed, the results indicated a 
strong linear relationship (ρ = 0.96) between ethnomedicinal taxa (grouped by order), and 
total taxa in those orders (Table 4). The population variance of the 43 order residuals 
(12.03) was employed as a cut-off; again, seven positive and five negative outlying 
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orders were identified (Table 5), which could be secondarily evaluated for 
ethnopharmacological insights. 
 
Insert Table 4 
 
Insert Table 5 
 
Growth forms of the positive outlying orders identified in the primary regression analysis 
were analysed, with results presented as stacked bar charts (Figure 3). In southern Africa, 
the Asterales and Solanales comprise predominantly herb-like plants and/or dwarf shrubs, 
while the Sapindales has a greater representation of trees and/or shrubs. Other orders such 
as the Fabales and Malpighiales have an approximately even mix of growth forms 
between trees/shrubs and herbs/dwarf shrubs. The Gentianales have the highest 
percentage of geophytes and climbers within the group. It is not possible at order level to 
assign significance to any particular growth forms as such a wide range are utilised 
(Figure 3). It is likely that the distribution of growth forms of ethnomedicinal taxa in 
‘hot’ orders are representative of the growth forms for each order as a whole. Moerman 
(1979) noted that there ‘appears to be some kind of order to the collective ethnobotanical 
wisdom [of Native Americans] in that the plants they use do show a high likelihood of 
producing biologically active secondary products’. However, while there may similarly 
be an ordered basis for plant selection by ethnomedicinal practitioners in the FSA region, 
this is not apparent from an analysis of growth forms (Figure 3). As such, growth forms 
of southern African ethnomedicinals would not prove useful as weighted criteria in semi-
quantitative selection procedures. However, plants have many other characteristics such 
as the colour/shape/smell and size of fruits, seeds, leaves and flowers, a number of which 
may influence the selection behaviour of traditional users. Etkin (1986) noted that plant 
selection by ethnomedicinal practitioners may be patterned in accordance with the belief 
that certain attributes (e.g. leaf shape or colour) serve to indicate utility relative to a 
particular ailment or disease. This concept is referred to generally as the Doctrine of 
Signatures. 
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Insert Figure 3 
 
 
Data mining results of compound class data for selected plant families (DNP, 
2005) were grouped by class and percentage, relative to the total number of compounds 
known from each family globally (Table 6).  
 
Insert table 6 
 
Of the families of most significant regional interest (Table 6), the Fabaceae have the 
greatest percentage of flavonoids, followed by the Anacardiaceae, whilst the Rubiaceae 
have the greatest percentage alkaloids, followed by the Convolvulaceae. Terpenoid 
natural products and their derivatives were the dominant compound class for the 
Asteraceae and Euphorbiaceae. Accordingly, many ‘hot’ ethnomedicinal families are rich 
in chemical classes with known bioactive metabolites such as flavonoids, alkaloids and 
terpenoids (Balandrin et al., 1985; Bruneton, 1995; Yao et al., 2004). This finding 
concurs with previous reports that show ethnobotanical plant selections, (relative to 
random selections), yield better results by enhancing hit rates of pharmacologically active 
compounds (Hamburger and Hostettmann, 1991; Macilwain, 1998; Marles and 
Farnsworth, 1994; Soejarto, 1993). A detailed knowledge of compound class proportions 
in plants could potentially be applied in weighted selection systems to prioritise candidate 
taxa for bioactivity evaluation. 
It was assumed, for the purpose of this study, that individual ethnomedicinal taxa 
are efficacious against the diseases for which they are reportedly used. Their 
phytochemical traits were thus regarded as being correlated through common descent as 
opposed to convergent evolution. The assumptions were based on reports that most kinds 
of secondary compounds, including tannins and alkaloids, are phylogenetically 
conservative in their distribution (Silvertown and Dodd, 1996). The isolation of popular 
ethnomedicinal orders/families by means of regression analyses is therefore considered 
appropriate for i) the identification of related taxa with similar bioactive constituents and 
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ii) the prioritisation of taxa for bioprospecting purposes. As detailed phylogenies were 
not incorporated into the analyses, all species were treated as independent data points. 
The phylogenetic independence of claimed relationships was therefore not confirmed and 
some degree of pseudo replication is expected (Silvertown and Dodd, 1996). 
Understanding why different plants produce different secondary metabolites is an 
important consideration in the field of bioprospecting, as such insights allow for 
optimising of plant selections. The previously accepted consensus, that secondary 
metabolite production was related primarily to enhancing the fitness of the producer, has 
been undermined by data from pharmaceutical and agrochemical industries (Firn, 2003). 
Firn reported that the pharmaceutical and agrochemical industries, through experience 
with numerous screening programmes, have realised that a very low probability exists of 
finding useful compounds from either man-made or naturally made chemicals. This, 
according to Firn and Jones (2000) is due to the requirement of a very precise three-
dimensional match between charge distribution on an efficacious biochemical compound 
and the surface of the target protein it is required to interact with. Jones and Firn (1991) 
have proposed that evolution favours organisms that can generate and retain the greatest 
sustainable chemical diversity at lowest cost. Such organisms would have an increased 
likelihood of enhanced fitness due to the greater chances of producing rare chemicals 
with potent biological activity. As such, the majority of natural products found in plants 
are unlikely to possess potent biological activity. If this argument is accepted, then 
bioprospectors need to identify those taxa with high chemical diversity as these would 
then provide the greatest potential for drug development. Table 6 reveals that the 
Euphorbiaceae is particularly diverse chemically, with no less than 1.7% representation 
of any major constituent class. This same family has contributed most to the outlier status 
of its respective order, the Malpigiales (Table 3), which has been used significantly 
greater than predicted (Table 2). In that the Euphorbiaceae is therefore a good 
bioprospecting taxon on which to focus, the value of combining data on ethnomedicinal 
applications and phylogenetics is exampled. 
Native Americans have shown a predilection for selecting particular 
ethnomedicinal families, regardless of family size (Moerman et al., 2003). This is likely 
due to related plants showing similar efficacy against certain diseases of man due to 
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heritable similarities in secondary metabolites, in which case phylogenetic considerations 
are important in the selection of candidate bioprospecting subjects. Although disputed by 
some influential systematists it is generally accepted that related taxa share chemical 
characteristics, to the extent that phytochemicals can be used as taxonomic characters in 
classification (Cronquist, 1980; Grayer et al., 1999; Waterman, 1999). The early work by 
Robert Hegnauer is particularly relevant (Grayer et al., 1999) due to his attempt to 
understand the distribution of secondary (and some primary) metabolites in the plant 
kingdom and the phylogenetic relationships of plant families based on chemical profiles 
(Grayer et al., 1999). Hegnauer's early work was controversial but it was later endorsed 
by a number of systematists (Dahlgren, 1975; Thorne, 1981), who included chemical 
characters when constructing their classifications. 
The structural diversity of plant compounds has likely increased along with other 
changes observed in the course of plant evolution (Hegnauer, 1967; Heinrich et al., 
2004). Certain compound classes are sometimes restricted taxonomically, e.g. 
sesquiterpene lactones are limited to the Asteraceae, Apiaceae, Burseraceae, Lauraceae 
and Magnoliaceae (Dahlgren et al., 1981). Records documenting the occurrence of 
pharmacologically active secondary metabolites within monophyletic assemblages are 
therefore of particular interest. Homology in such groups, may lead to the evolution of 
compounds with similar pharmacological activity. Alternatively, production of the same 
or similar compounds in unrelated taxa through convergent evolution may be an indicator 
of endowed selective fitness due to compound efficacy (Dahlgren et al., 1981). 
Compound classes present across broad polyphyletic groups are generally unlikely to aid 
bioprospectors identify particularly efficacious taxa. However, convergent clades with 
known efficacious taxa may prove useful through the provision of independent sets of 
relatives to investigate. The divergent, convergent or parallelist nature of biosynthetic 
pathways producing such compounds may also prove insightful to chemists attempting 
laboratory syntheses. 
Comparative methods (e.g. least squares regression analyses) are common tools 
for investigating trait correlations (Felsenstein, 1985; Harvey and Pagel, 1991; Westoby 
et al., 1995). However, the current lack of detailed phylogenies for the majority of 
southern African higher order taxa will likely generate some degree of pseudo replication 
 16
when applied locally. Further, whilst this study has assumed a census dataset it is 
acknowledged that historical regional human settlement patterns, and subsequent socio-
cultural interactions, may have significantly shaped the documented body of traditional 
plant-use knowledge (e.g. Watt and Breyer-Brandwijk 1962; SANBI 2004). This last-
mentioned factor could well skew the results of any regression analyses, and accordingly 
is worth investigating. 
Conclusions 
 
The use of regression analyses has allowed for the identification of plant orders and 
consequently families most highly selected for by traditional healers in southern Africa. 
The approach taken allows for flexibility in that assessments can be undertaken at a 
variety of taxonomic levels. The current analyses identified seven ‘hot’ plant orders (the 
Malpigiales, Fabales, Gentianales, Asteraceae, Solanales, Malvales and Sapindales in 
decreasing order of bias by user groups) and ‘hot’ families therein that hold significantly 
more ethnomedicinal taxa than predicted. The magnitude of the outlying residuals 
falsified the null hypothesis that traditional user-groups in the region select plants for 
medicinal purposes in a wholly random manner. An assessment of growth forms of taxa 
in ‘hot’ orders failed to elucidate the role this factor might play in plant selections by 
ethnomedicinal practitioners. An analysis of the dominant chemical compound classes of 
the ‘hottest’ plant families from ‘hot’ plant orders revealed that these taxa are 
documented to produce a wide variety of pharmacologically-active compounds. The 
results obtained overall are considered potentially useful in the rational prioritisation of 
plant subjects for regional ethnopharmacology studies, and in optimising bioprospecting 
ventures. This is particularly so when findings are applied in conjunction with the latest 
chemotaxonomic data available for the identified plant families.  
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